GGrantIndex
← Search

STUDY EVALUATING SDZ RAD IN DE NOVO RENAL TRANSPLANT RECIPIENTS

$0M01FY2001RRNIH

Yale University, New Haven CT

Investigators

Linked publications & trials

Abstract

A One-year, multicenter, randomized, double-blind, dose finding study to evaluate the safety, tolerability and pharmacokinetics of SDZ RAD in DeNovo Renal Transplant Recipients (RADB-157 Version 040998).

View original record on NIH RePORTER →